ClinicalMetric / Countries / Italy / esophageal cancer
← 🇮🇹 Italy Trials
🇮🇹 Italy Country × Condition

esophageal cancer Clinical Trials in Italy

Active clinical trials for esophageal cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇮🇹 Italy

Active Trials in Italy (3)

NCT04498767
Recruiting

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

Enrollment
200 pts
Country
🇮🇹 Italy
European Organisation for Research ...
View Trial →
NCT04075305
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment
8,000 pts
Country
🇮🇹 Italy
UMC Utrecht
View Trial →
NCT05983432 Phase 1
Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Enrollment
470 pts
Country
🇮🇹 Italy
SystImmune Inc.
View Trial →

Frequently Asked Questions

How many esophageal cancer clinical trials are active in Italy?
There are currently 3 active clinical trials for esophageal cancer with sites in Italy, of which 3 are actively recruiting patients.
How can I join a esophageal cancer clinical trial in Italy?
To join a esophageal cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are esophageal cancer trials in Italy?
Active esophageal cancer trials in Italy span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Italy Trials → Global esophageal cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology